Stay updated on BLASST-1: Nivolumab Combo in MIBC Clinical Trial
Sign up to get notified when there's something new on the BLASST-1: Nivolumab Combo in MIBC Clinical Trial page.

Latest updates to the BLASST-1: Nivolumab Combo in MIBC Clinical Trial page
- Check2 days agoChange DetectedThe page's revision label in the metadata was updated from v3.5.3 to v3.5.4. This update indicates an internal versioning change rather than a modification to the trial details.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has been updated to a newer ClinicalTrials.gov revision identifier (v3.5.3), replacing the previous one (v3.5.2) without changing the underlying study information.SummaryDifference0.1%

- Check30 days agoChange DetectedRevision: v3.5.2 updated from v3.5.0.SummaryDifference0.1%

- Check59 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check66 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check80 days agoChange DetectedCore study content (inclusion criteria, outcomes, locations, and interventions) appears unchanged; the updates seem limited to layout and formatting changes.SummaryDifference0.1%

Stay in the know with updates to BLASST-1: Nivolumab Combo in MIBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BLASST-1: Nivolumab Combo in MIBC Clinical Trial page.